SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-008073
Filing Date
2020-03-30
Accepted
2020-03-30 17:30:18
Documents
4
Period of Report
2020-03-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea120117-8k_artaratherap.htm 8-K 29623
2 ARTARA THERAPEUTICS, INC. INDUCEMENT PLAN ea120117ex10-1_artaratherap.htm EX-10.1 150088
3 FORM OF STOCK OPTION GRANT NOTICE AND STOCK OPTION AGREEMENT UNDER ARTARA THERAP ea120117ex10-2_artaratherap.htm EX-10.2 80765
4 FORMS OF RESTRICTED STOCK UNIT GRANT NOTICE AND RESTRICTED STOCK UNIT AGREEMENT ea120117ex10-3_artaratherap.htm EX-10.3 70885
  Complete submission text file 0001213900-20-008073.txt   332550
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
ArTara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36694 | Film No.: 20758608
SIC: 2836 Biological Products, (No Diagnostic Substances)